Ascertain Biotech develops artificial intelligence solutions specifically for healthcare applications. The company focuses on addressing unmet clinical needs within specialized surgical fields like spine and plastic surgery. Their AI platform also extends to providing support for depression management protocols.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional spine and plastic surgeries often suffer from inefficiencies and risks that can negatively impact patient outcomes. Current methods for managing depression may lack the precision and data-driven insights needed for optimal treatment.
Solution
Ascertain Biotech leverages artificial intelligence to improve the precision and effectiveness of spine and plastic surgeries. Their technology provides surgeons with data-driven tools to enhance surgical planning, execution, and post-operative care, potentially leading to better patient outcomes and reduced complications. Additionally, Ascertain Biotech offers AI-powered solutions for depression management, aiming to provide clinicians with enhanced insights and support for personalized treatment strategies. By integrating AI into these critical areas of healthcare, Ascertain Biotech seeks to optimize both surgical procedures and mental health interventions.
Target Audience
Ascertain Biotech's primary customers include spine surgeons, plastic surgeons, hospitals, and mental health professionals seeking to improve patient outcomes and operational efficiency through the use of AI-driven technologies.
Features
- AI-driven surgical planning tools for spine and plastic surgeries
- Real-time surgical guidance systems to enhance precision during procedures
- Post-operative analytics to monitor patient recovery and identify potential complications
- AI-powered platform for depression management, offering data-driven insights
- Personalized treatment recommendations based on patient-specific data